These findings demonstrate that AFP gene abundance measure from cfDNA offers superior diagnostic capabilities compared to conventional serum AFP and other liver function markers in serum, demonstrating its potential as a more reliable biomarker for HCC detection. The gene discussed is AFP; the disease is hepatocellular carcinoma.